Emma Cartmell, Angel Investor

Emma is a healthcare industry operator, successful investor and sought after Board Member. Most recently, Emma was Managing Partner at Cartmell Ventures where she made 14 digital health investments. Additionally, Emma is an advisor to Morgan Stanley's Expansion Capital Fund and United Health Groups accelerator program. Previously, she served on the board of HIMSS North America and advised the British Government on digital health. Emma was also the founding COO for NantHealth where she oversaw over 30 digital health investments, worked as COO for Abraxis BioScience which was sold to Celgene for over $3B dollars, and served as SAIC's Vice President of business development for the Health Solutions Business Unit and VP of Healthcare Advance Programs. With over two decades of proven leadership and investment success, Emma values leveraging technology to fix broken workflows in healthcare delivery to create an effortless patient experience, improve health outcomes and lower costs for all.